News from NHLBI: Nutrition Research at the National Heart, Lung, and Blood Institute and Future Opportunities.


Journal

The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243

Informations de publication

Date de publication:
11 03 2021
Historique:
received: 13 10 2020
revised: 21 10 2020
accepted: 24 11 2020
pubmed: 10 2 2021
medline: 13 5 2021
entrez: 9 2 2021
Statut: ppublish

Résumé

Nutrition plays a major role in the prevention and treatment of cardiovascular and other chronic diseases; hence, nutrition research is a priority for the National Heart, Lung, and Blood Institute (NHLBI). The purpose of this analysis is to describe the scope of NHLBI-funded extramural nutrition research grants over the past decade and offer insights into future opportunities for nutrition research relevant to NHLBI's mission. Data were extracted using the Research, Condition, and Disease Categorization spending categories from the publicly available NIH Research Portfolio Online Reporting Tool Expenditures and Results. New 2018 and 2019 grants were coded into categories and mapped to the 2016 NHLBI Strategic Vision priorities. Approximately 90% of nutrition research funds supported extramural grants, particularly through investigator-initiated R series grants (69.6%). Of these, 19.8% were classified as clinical trials. Consistent nutrition-related topics, including physical activity, weight loss, fatty acids, metabolic syndrome, childhood obesity, and other topics such as gut microbiota, arterial stiffness, sleep duration, and meal timing, emerged in 2014-2019.  Mapping of the NHLBI Strategic Vision objectives revealed that 32% of newly funded grants focused on pathobiological mechanisms important to the onset and progression of heart, lung, blood, and sleep disorders, with opportunities including developing novel diagnostic and therapeutic strategies and clinical and implementation science research. The findings show the breadth of NHLBI-funded nutrition research and highlight potential research opportunities for nutrition scientists.

Sections du résumé

BACKGROUND
Nutrition plays a major role in the prevention and treatment of cardiovascular and other chronic diseases; hence, nutrition research is a priority for the National Heart, Lung, and Blood Institute (NHLBI). The purpose of this analysis is to describe the scope of NHLBI-funded extramural nutrition research grants over the past decade and offer insights into future opportunities for nutrition research relevant to NHLBI's mission.
METHODS
Data were extracted using the Research, Condition, and Disease Categorization spending categories from the publicly available NIH Research Portfolio Online Reporting Tool Expenditures and Results. New 2018 and 2019 grants were coded into categories and mapped to the 2016 NHLBI Strategic Vision priorities.
RESULTS
Approximately 90% of nutrition research funds supported extramural grants, particularly through investigator-initiated R series grants (69.6%). Of these, 19.8% were classified as clinical trials. Consistent nutrition-related topics, including physical activity, weight loss, fatty acids, metabolic syndrome, childhood obesity, and other topics such as gut microbiota, arterial stiffness, sleep duration, and meal timing, emerged in 2014-2019.  Mapping of the NHLBI Strategic Vision objectives revealed that 32% of newly funded grants focused on pathobiological mechanisms important to the onset and progression of heart, lung, blood, and sleep disorders, with opportunities including developing novel diagnostic and therapeutic strategies and clinical and implementation science research.
DISCUSSION
The findings show the breadth of NHLBI-funded nutrition research and highlight potential research opportunities for nutrition scientists.

Identifiants

pubmed: 33561207
pii: S0022-3166(22)00084-0
doi: 10.1093/jn/nxaa413
pmc: PMC8189012
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

598-604

Informations de copyright

Published by Oxford University Press on behalf of the American Society for Nutrition 2021.

Références

Adv Nutr. 2013 Sep 01;4(5):579-84
pubmed: 24038264
Circulation. 2016 Jan 12;133(2):187-225
pubmed: 26746178
JAMA. 2020 Aug 25;324(8):735-736
pubmed: 32766768

Auteurs

Alison G M Brown (AGM)

Clinical Applications and Preventions Branch, Division of Cardiovascular Science, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.

Travis Hyams (T)

Clinical Applications and Preventions Branch, Division of Cardiovascular Science, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
Department of Behavioral and Community Health, School of Public Health, University of Maryland, College Park, MD, USA.

Alanna N Brown (AN)

Clinical Applications and Preventions Branch, Division of Cardiovascular Science, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
Environmental and Health Sciences Program, Spelman College, Atlanta, GA, USA.

Holly Nicastro (H)

Clinical Applications and Preventions Branch, Division of Cardiovascular Science, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.

Charlotte A Pratt (CA)

Clinical Applications and Preventions Branch, Division of Cardiovascular Science, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH